Indian Journal of Respiratory Care

IJRC Email      Register      Login

VOLUME 12 , ISSUE 2 ( April-June, 2023 ) > List of Articles

Original Article

Survey on the Impact of COVID-19 Mandatory Lockdown on Clinical Condition of Patients with Chronic Pulmonary Diseases

Farrokh Fathi Moghaddam, Mahnaz Amini, Milad Bahrami, Fariba Rezaeetalab, Negar Gholampoor Shamkani, Mahdi Rafiee, Mahnaz Mozdourian

Keywords : Coronavirus 2019, Chronic obstructive pulmonary disease, Interstitial lung disease, Asthma, Quarantine

Citation Information : Moghaddam FF, Amini M, Bahrami M, Rezaeetalab F, Shamkani NG, Rafiee M, Mozdourian M. Survey on the Impact of COVID-19 Mandatory Lockdown on Clinical Condition of Patients with Chronic Pulmonary Diseases. Indian J Respir Care 2023; 12 (2):113-117.

DOI: 10.5005/jp-journals-11010-1030

License: CC BY-NC-SA 4.0

Published Online: 30-06-2023

Copyright Statement:  Copyright © 2023; The Author(s).


Introduction: The coronavirus disease of 2019 (COVID-19) pandemic has prompted lockdown regulations and extreme societal restrictions worldwide. The current study intended to assess the impact of the COVID-19 mandatory lockdown on the clinical condition of patients with chronic pulmonary diseases. Materials and methods: A telephone survey was carried out on patients with chronic pulmonary diseases who were referred to Imam Reza Hospital in Mashhad, Iran, from March 2019 to June 2020. The collected information included the subjects’ demographic characteristics, their compliance with lockdown mandates, the feasibility of access to medical care and medications, exacerbation of their underlying chronic pulmonary diseases and in case of COVID-19 development, their clinical presentations, and length of hospital stay (if hospitalized). Results: A total of 500 patients, including 291 males (58.2%) and 209 females (41.8%), participated in the present study. According to the findings of interviews, 93.6% of participants strictly followed the lockdown rules, and 44.4% had a face-to-face or phone consultation with a pulmonologist. Additionally, 35.7% of patients were diagnosed with COVID-19, of whom 70.4% were hospitalized, and 15.6% died. Dyspnea, fever, cough, headache, and fatigue were the most prevalent symptoms reported by COVID-19 patients. Conclusion: The government lockdown policies have hindered access to health services, especially for those suffering from chronic pulmonary diseases. Under this condition, COVID-19 disease can further place patients with chronic pulmonary diseases at risk as infection in these patients progresses more rapidly. Therefore, in the current crisis, patients with chronic pulmonary diseases need to be supervised by specialist consultants and receive adequate medical care constantly.

PDF Share
  1. Velavan TP, Meyer CG. The COVID-19 epidemic. Trop Med Int Health 2020;25(3):278–280. DOI: 10.1111/tmi.13383
  2. Organization WH. COVID-19 weekly epidemiological update, 6 April 2021. 2021.
  3. Yuki K, Fujiogi M, Koutsogiannaki S. COVID-19 pathophysiology: a review. Clin Immunol 2020;215:108427. DOI: 10.1016/j.clim.2020.108427
  4. Gupta A, Madhavan MV, Sehgal K, et al. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26(7):1017–1032. DOI: 10.1038/s41591-020-0968-3
  5. Emami A, Javanmardi F, Pirbonyeh N, et al. Prevalence of underlying diseases in hospitalized patients with COVID-19: a systematic review and meta-analysis. Arch Acad Emerg Med 2020;8(1):e35. DOI: 10.22037/aaem.v8i1.600
  6. Alfawaz H, Amer OE, Aljumah AA, et al. Effects of home quarantine during COVID-19 lockdown on physical activity and dietary habits of adults in Saudi Arabia. Sci Rep 2021;11(1):1–7. DOI: 10.1038/s41598-021-85330-2
  7. Cetron M, Landwirth J. Public health and ethical considerations in planning for quarantine. Yale J Biol Med 2005;78(5):329–334.
  8. Mattioli AV, Ballerini Puviani M, Nasi M, et al. COVID-19 pandemic: the effects of quarantine on cardiovascular risk. European journal of clinical nutrition. 2020;74(6):852–855. DOI: 10.1038/s41430-020-0646-z
  9. Ahmed SAKS, Ajisola M, Azeem K, et al. Impact of the societal response to COVID-19 on access to healthcare for non-COVID-19 health issues in slum communities of Bangladesh, Kenya, Nigeria and Pakistan: results of pre-COVID and COVID-19 lockdown stakeholder engagements. BMJ Glob Health 2020;5(8):e003042. DOI: 10.1136/bmjgh-2020-003042
  10. Qaseem A, Wilt TJ, Weinberger SE, et al. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med 2011;155(3):179–191. DOI: 10.7326/0003-4819-155-3-201108020-00008
  11. Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011;183(6):788–824. DOI: 10.1164/rccm.2009-040GL
  12. Holguin F, Cardet JC, Chung KF, et al. Management of Severe Asthma: a European Respiratory Society/American Thoracic Society Guideline. Eur Respir J 2020;55:1900588. DOI: 10.1183/13993003.00588-2019
  13. Kiani FZ, Ahmadi A, Babadi AS, et al. Profile and preliminary results of Iranian sub cohort chronic obstructive pulmonary disease (COPD) in Shahrekord PERSIAN cohort in southwest Iran. BMC Pulm Med 2021;21(1):105. DOI: 10.1186/s12890-021-01469-8
  14. Pleguezuelos E, Del Carmen A, Moreno E, et al. The experience of COPD patients in lockdown due to the COVID-19 pandemic. Int J Chron Obstruct Pulmon Dis 2020;15:2621–2627. DOI: 10.2147/COPD.S268421
  15. Stokes EK, Zambrano LD, Anderson KN, et al. Coronavirus disease 2019 case surveillance - United States, January 22-May 30, 2020. MMWR Morb Mortal Wkly Rep 2020;69(24):759–765. DOI: 10.15585/mmwr.mm6924e2
  16. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395(10223):497–506. DOI: 10.1016/S0140-6736(20)30183-5
  17. Goyal P, Choi JJ, Pinheiro LC, et al. Clinical characteristics of Covid-19 in New York City. N Engl J Med 2020;382(24):2372–2374. DOI: 10.1056/NEJMc2010419
  18. Eythorsson E, Helgason D, Ingvarsson RF, et al. Clinical spectrum of coronavirus disease 2019 in Iceland: population based cohort study. BMJ 2020;371:m4529. DOI: 10.1136/bmj.m4529
  19. Song J, Zeng M, Wang H, et al. Distinct effects of asthma and COPD comorbidity on disease expression and outcome in patients with COVID-19. Allergy 2021;76(2):483–496. DOI: 10.1111/all.14517
  20. He Y, Xie M, Zhao J, et al. Clinical characteristics and outcomes of patients with severe COVID-19 and chronic obstructive pulmonary disease (COPD). Med Sci Monit 2020;26:e927212. DOI: 10.12659/MSM.927212
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.